Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 188.41

-2.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (4307)	7/26/1997 7:16:00 AM
From: Henry Niman	of 32384

Andy, If you look at the abstract of the Nature paper, you will see that it came out of the Department of Cardiovascular Research, Ligand Pharmaceuticals, San Diego, California 92121, USA. LGND has an extensive PPAR and TZD program (with applications in their GLX alliance) and I'm sure that they are well aware of applications beyond diabetes. Their recent paper on the various isoforms of PPAR gamma was also out of their Cadiovascular Research Department. Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next